Vitamin D deficiency and risk for rheumatic diseases: An update

Current Opinion in Rheumatology

Volumn 25, Issue 2, 2013, Pages 184-191

  Gatenby, Paul ^a   Lucas, Robyn ^b   Swaminathan, Ashwin ^a,b  

^a The Australian National University   (Australia)

^b The Australian National University   (Australia)

Author keywords

rheumatic disease; rheumatoid arthritis; systemic lupus erythematosus; vitamin D

Indexed keywords

VITAMIN D;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; BEHCET DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOMODULATION; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PROPHYLAXIS; PSORIATIC ARTHRITIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SCLERODERMA; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; TH1 CELL; TH17 CELL; TH2 CELL; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ARTHRITIS, RHEUMATOID; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATIC DISEASES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84873334895     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835cfc16     Document Type: Review

References (95)

1. Bikle DD. What is newin vitamin D: 2006-2007. Curr Opin Rheumatol 2007; 19:383-388.
2. Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008; 20:532-537.
3. Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009; 21:279-283.
4. Lai JK, Lucas RM, Banks E, Ponsonby AL. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 2012; 42:43-50.
5. Holick MF. The vitamin D deficiency pandemic and consequences for non-skeletal health: mechanisms of action. Mol Aspects Med 2008; 29:361-368.
6. Broder AR, Tobin JN, Putterman C. Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and nonautoimmune chronic diseases: a retrospective comparison ofthree chronic diseases. Arthritis Res Ther 2010; 12:R191.
7. Ponsonby AL, Lucas RM, van der Mei IA. UVR, vitamin D and three auto-immune diseases: multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 2005; 81:1267-1275.
8. Disanto G, Chaplin G, Morahan JM, et al. Month of birth, vitamin D and risk of immune mediated disease: a case control study. BMC Med 2012; 10:69.
9. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology 2011; 134:123-139.
10. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin North Am 2012; 38:125-139.
11. Hewison M. Vitamin D and immune function: autocrine, paracrine or endo-crine? Scand J Clin Lab Invest Suppl 2012; 243:92-102.
12. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol 2011;11:584-596.
13. Adorini L, Penna G, Giarratana N, et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004; 89-90:437-441.
14. van der Aar AM, Sibiryak DS, Bakdash G, et al. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J Allergy Clin Immunol 2011; 127:1532-1540; e1537.
15. Almerighi C, Sinistro A, Cavazza A, et al. 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009; 45:190-197.
16. Baeke F, Takiishi T, Korf H, et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10:482-496.
17. Baeke F, Korf H, Overbergh L, et al. Human Tlymphocytesaredirecttargetsof 1, 25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010; 121:221-227.
18. Boonstra A, Barrat FJ, Crain C, et al. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974-4980.
19. Overbergh L, Decallonne B, Waer M, et al. 1alpha, 25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000; 49:1301-1307.
20. Bikle DD. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep 2009; 7:58-63.
21. Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324:23-33.
22. Urry Z, Xystrakis E, Richards DF, et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha, 25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 2009; 119:387-398.
23. Chen S, Sims GP, Chen XX, et al. Modulatoryeffectsof 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179:1634-1647.
24. Zold E, Barta Z, Bodolay E. Vitamin D deficiency and connective tissue disease. Vitam Horm 2011; 86:261-286.
25. Luong K, Nguyen LT. The beneficial role of vitamin D in systemic lupus erythematosus (SLE). Clin Rheumatol 2012; 31:1423-1435.
26. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, et al. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 2012; 21:477-484.
27. Cutillas-Marco E, Morales-Suarez-Varela M, Marquina-Vila A, Grant W. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 2010; 19:810-814.
28. Damanhouri LH. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 2009; 30:1291-1295.
29. Hamza RT, Awwad KS, Ali MK, Hamed AI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 2011; 17: CR711-CR718.
30. Heine G, Lahl A, Muller C, Worm M. Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. Br J Dermatol 2010; 163:863-865.
31. Kim HA, Sung JM, Jeon JY, et al. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int 2011;31:1189-1194.
32. Munoz-Ortego J, Torrente-Segarra V, Prieto-Alhambra D et al. Prevalenceand predictors of vitamin D deficiency in nonsupplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. Scand J Rheumatol 2012; 41:472-475.
33. Souto M, Coelho A, Guo C, et al. Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationshipwith activity. Lupus 2011; 20:1019-1026.
34. Ritterhouse LL, Crowe SR, Niewold TB, et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011; 70:1569-1574.
35. Wright TB, Shults J, Leonard MB, et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155:260-265.
36. Gilkeson G, James J, Kamen D, et al. The United States to Africa lupus prevalence gradient revisited. Lupus 2011; 20:1095-1103.
37. Costenbader KH, Feskanich D, Holmes M, et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67:530-535.
38. Hiraki LT, Munger KL, Costenbader KH, Karlson EW. Dietary intake of vitamin D during adolescence and risk of adult onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64:1829-1836.
39. Mok CC, Birmingham DJ, Ho LY, et al. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with antidsDNA and anti-C1q. Lupus 2012; 21:36-42.
40. Mok CC, Birmingham DJ, Leung HW, et al. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 2012; 51:644-652.
41. Yeap SS, Othman AZ, Zain AA, Chan SP. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malay-sian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis 2012; 15:17-24.
42. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 2011; 20:1155-1160.
43. Amital H, Szekanecz Z, Szucs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69:1155-1157.
44. Toloza SM, Cole DE, Gladman DD, et al. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010; 19:13-19.
45. Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010; 5:e9193.
46. Birmingham DJ, Hebert LA, Song H, et al. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012; 21:855-864.
47. Casella CB, Seguro LP, Takayama L, et al. Juvenile Onset Systemic Lupus Erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 2012; 21:1335-1342.
48. Robinson AB, Thierry-Palmer M, Gibson KL, Rabinovich CE. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythema-tosus and juvenile dermatomyositis. J Pediatr 2012; 160:297-302.
49. Ruiz-Irastorza G, Gordo S, Olivares N, et al. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010; 62:1160-1165.
50. Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical conse-quences. Rheumatology (Oxford) 2008; 47:920-923.
51. Breslin LC, Magee PJ, Wallace JM, McSorley EM. An evaluation of vitamin D status in individuals with systemic lupus erythematosus. Proc Nutr Soc 2011; 70:399-407.
52. Lee YH, Bae SC, Choi SJ, et al. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and sys-temic lupuserythematosus: a meta-analysis. Mol Biol Rep 2011; 38:3643-3651.
53. Luo XY, Yang MH, Wu FX, et al. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythema-tosus in a Han Chinese population. Lupus 2012; 21:53-59.
54. Abbasi M, Rezaieyazdi Z, Afshari JT, et al. Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythe-matosus. Rheumatol Int 2010; 30:1537-1539.
55. Monticielo OA, Brenol JC, Chies JA, et al. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 2012; 21:43-52.
56. Doria A, Arienti S, Rampudda M, et al. Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 2008; 7:192-197.
57. Ramos-Remus C, Sierra-Jimenez G, Skeith K, et al. Latitude gradient influ-ences the age of onset in rheumatoid arthritis patients. Clin Rheumatol 2007; 26:1725-1728.
58. Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50:72-77.
59. Heidari B, Hajian-Tilaki K, Heidari P. The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatol Int 2012; 32:991-995.
60. Cooles FA, Pratt AG, Wilson G, et al. Prevalence and diagnostic outcome relating to vitamin D deficiency in new patients presenting to an early arthritis clinic over 12 months. Clin Rheumatol 2011; 30:1137-1138.
61. Feser M, Derber LA, Deane KD, et al. Plasma 25, OH vitamin D concentra-tions are not associated with rheumatoid arthritis (RA)-related auto-antibodies in individuals at elevated risk for RA. J Rheumatol 2009; 36:943-946.
62. Welsh P, Peters MJ, Sattar N. Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis Rheum 2011; 63:1763-1769.
63. Welsh P, Peters MJ, McInnes IB, et al. Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFalpha blockade: results from a prospective cohort study. Ann Rheum Dis 2011; 70:1165-1167.
64. Hasan E, Olusi S, Al-Awadhi A, et al. Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis. Biologics 2012; 6:31-35.
65. Cutolo M, Otsa K, Laas K, et al. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006; 24:702-704.
66. Kerr GS, Sabahi I, Richards JS, et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 2011; 38:53-59.
67. Rossini M, Maddali Bongi S, La Montagna G, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010; 12:R216.
68. Craig SM, Yu F, Curtis JR, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheuma-toid arthritis. J Rheumatol 2010; 37:275-281.
69. Baker JF, Baker DG, Toedter G et al. Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 2012; 30:658-664.
70. Hitchon CA, Sun Y, Robinson DB, et al. Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol 2012; 39:1792-1797.
71. Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheuma-tologic disorders. Autoimmun Rev 2010; 9:507-510.
72. Gopinath K, Danda D. Supplementation of 1, 25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised con-trolled trial. Int J Rheum Dis 2011; 14:332-339.
73. Bansal AS, Henriquez F, Sumar N, Patel S. T helper cell subsets in arthritis and the benefits of immunomodulation by 1, 25(OH)(2) vitamin D. Rheumatol Int 2012; 32:845-852.
74. van Hamburg JP, Asmawidjaja PS, Davelaar N, et al. TNF blockade requires 1, 25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis 2012; 71:606-612.
75. Harari M, Dramsdahl E, Shany S, et al. Increased vitamin D serum levels correlate with clinical improvement of rheumatic diseases after Dead Sea climatotherapy. Isr Med Assoc J 2011; 13:212-215.
76. Ellis JA, Munro JE, Ponsonby AL. Possible environmental determinants of juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49:411-425.
77. Pelajo CF, Lopez-Benitez JM, Miller LC. 25-hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol 2011; 38:2000-2004.
78. Gatenby PA, Lucas RM, Engelsen O, et al. Antineutrophil cytoplasmic anti-body-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 2009; 61:1417-1424.
79. Orgaz-Molina J, Buendia-Eisman A, Arrabal-Polo MAet al. Deficiencyofserum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol 2012; 67:931-938.
80. Touma Z, Eder L, Zisman D, et al. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care Res (Hoboken) 2011; 63:1440-1447.
81. Braun-Moscovici Y, Toledano K, Markovits D, et al. Vitamin D level: isitrelated to disease activity in inflammatory joint disease? Rheumatol Int 2011; 31:493-499.
82. Gaal J, Lakos G, Szodoray P, et al. Immunological and clinical effects of alphacalcidol in patientswith psoriaticarthropathy: results of an open, follow-up pilot study. Acta Derm Venereol 2009; 89:140-144.
83. Vacca A, Cormier C, Piras M, et al. Vitamin D deficiencyand insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 2009; 36:1924-1929.
84. Calzolari G, Data V, Carignola R, Angeli A. Hypovitaminosis D in systemic sclerosis. J Rheumatol 2009; 36:2844.
85. Caramaschi P, Dalla Gassa A, Ruzzenente O, et al. Very lowlevelsofvitamin D in systemic sclerosis patients. Clin Rheumatol 2010; 29:1419-1425.
86. Belloli L, Ughi N, Marasini B. Vitamin D in systemic sclerosis. Clin Rheumatol 2011; 30:145-146.
87. Arnson Y, Amital H, Agmon-Levin N, et al. Serum 25-OH vitamin D concen-trations are linked with various clinical aspects in patients with systemic sclerosis: aretrospective cohortstudyand reviewof the literature. Autoimmun Rev 2011; 10:490-494.
88. Gambichler T, Chrobok I, Hoxtermann S, Kreuter A. Significantly decreased serum 25-hydroxyvitamin d levels in a large german systemic sclerosis cohort. J Rheumatol 2011; 38:2492-2493.
89. Hamzaoui K, Ben Dhifallah I, Karray E, et al. Vitamin D modulates peripheral immunity in patients with Behcet's disease. Clin Exp Rheumatol 2010; 28:S50-S57.
90. Karatay S, Yildirim K, Karakuzu A, et al. Vitamin D status in patients with Behcet's Disease. Clinics (Sao Paulo) 2011; 66:721-723.
91. Karray EF, Ben Dhifallah I, Ben Abdelghani K, et al. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet's disease in Tunisians. Joint Bone Spine 2012; 79:144-148.
92. Durmus B, Altay Z, Baysal O, Ersoy Y. Does vitamin D affect disease severity in patients with ankylosing spondylitis? Chin Med J (Engl) 2012; 125:2511-2515.
93. Zold E, Szodoray P, Gaal J, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008; 10:R123.
94. Cutolo M, Otsa K, Paolino S, et al. Vitamin D involvement in rheumatoid arthritisand systemic lupuserythaematosus. Ann Rheum Dis 2009; 68:446-447.
95. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012; 12:127-136.